Oxycodone Hydrochloride
The full name of the medicine is Oxycodone Molteni. In this leaflet, it will be referred to as Oxycodone. The medicine contains the active substance oxycodone hydrochloride. It belongs to a group of medicines called painkillers (or "analgesics"). Oxycodone is used for the treatment of moderate to severe pain.
Before starting treatment with Oxycodone, you should discuss it with your doctor, pharmacist, or nurse if:
Tolerance, Dependence, and AddictionThis medicine contains oxycodone, which is an opioid. It can cause dependence and (or) addiction. Repeated use of opioid painkillers may lead to tolerance, so that you need higher doses to achieve the same level of pain relief. Repeated use of Oxycodone can lead to dependence, abuse, and addiction, which can be life-threatening. The risk of these side effects may be greater if you use higher doses or for longer than recommended. Dependence or addiction can mean that you cannot control how much of the medicine you use or how often you use it. You may feel a need to use the medicine even when it is no longer needed for pain relief. If you notice any of the following signs, it could mean that you are becoming dependent on or addicted to Oxycodone:
Sleep-Related Breathing DifficultiesOxycodone may cause sleep-related breathing difficulties, such as sleep apnea (pauses in breathing during sleep) and hypoxemia during sleep (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, waking up during the night feeling short of breath, difficulty staying asleep, or excessive daytime sleepiness. If you or someone else notices these symptoms, you should contact your doctor. Your doctor may consider reducing your dose.
Oxycodone should not be used in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, or might take, including those you have bought without a prescription, such as herbal medicines. Oxycodone may interact with other medicines, and other medicines may interact with Oxycodone. Concomitant use of Oxycodone and sedatives, such as benzodiazepines or similar medicines, increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and may be life-threatening. For this reason, concomitant use should only be considered when other treatment options are not possible.
Oxycodone should not be used during pregnancy unless your doctor considers it essential. Do not use Oxycodone during labor, as it may cause slow or shallow breathing (respiratory depression) or withdrawal symptoms in the newborn. If you are pregnant, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using Oxycodone.
Oxycodone should not be used during breastfeeding, as it may pass into breast milk.
Oxycodone may cause drowsiness, dizziness, or other side effects that can affect your ability to drive or use machines. Do not drive or operate machinery if you are affected.
Oxycodone Molteni contains less than 1 mmol of sodium per ampoule, which is essentially "sodium-free".
Before starting treatment and regularly during treatment, your doctor will discuss with you what to expect when using Oxycodone, when and how to use it, when to contact your doctor, and when to stop using it (see also "How to stop using Oxycodone"). Oxycodone is usually given by a doctor or nurse. The solution should be used immediately after opening.
The solution can be given in three ways:
Your doctor will decide the correct dose for you, depending on the severity of your pain. The dose and frequency of administration may be adjusted according to your pain level. The usual starting dose depends on the method of administration - your doctor will decide this. Usual starting doses are as follows:
If you experience inadequate pain relief after using Oxycodone, you should contact your doctor or pharmacist.
Oxycodone should not be used in children and adolescents under 18 years of age.
If you have kidney or liver problems, you should consult your doctor or pharmacist, as you may need a different dose or a different medicine.
Do not use more Oxycodone than your doctor has told you. If you think you have used too much Oxycodone (overdose), you should contact your doctor or go to the hospital immediately. Take the medicine pack with you. Do not drive or operate machinery. Symptoms of overdose may include:
Unless your doctor has told you to, do not suddenly stop using Oxycodone. If you want to stop using Oxycodone, you should discuss this with your doctor first. Your doctor will advise you on how to stop using Oxycodone gradually, to avoid withdrawal symptoms. If you stop using Oxycodone suddenly, you may experience withdrawal symptoms, such as:
If you have any further questions about using Oxycodone, ask your doctor or pharmacist.
Like all medicines, Oxycodone can cause side effects, although not everybody gets them.
Stop using Oxycodone and contact your doctor immediately if you experience any of the following severe side effects:
If you experience any of the following side effects, you should contact your doctor or nurse:
Very Common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Unknown Frequency:frequency cannot be estimated from the available data
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in the "Further information" section. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Store in a locked cupboard or other secure place, where other people cannot get to it. It can be very harmful and may cause death if taken by someone for whom it has not been prescribed. Do not use Oxycodone after the expiry date stated on the carton and ampoule label after EXP. Store in the original packaging to protect from light. After opening the ampoule, use the solution immediately. Dispose of any unused solution immediately. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Oxycodone is a clear, colorless solution in transparent glass ampoules. Oxycodone 50 mg/ml is available as a solution in 1 ml ampoules (containing 50 mg oxycodone hydrochloride).
Poland: Oxycodone Molteni United Kingdom: Oxycodone Molteni France: Oxycodone Molteni Italy: Ossicodone Molteni Date of Last Revision of the Leaflet: 02/2025
Oxycodone HydrochlorideThis leaflet provides specialized information for healthcare professionals about Oxycodone Molteni, 50 mg/ml, Solution for Injection/Infusion.
Dosage:The dosage should be adjusted according to the severity of the pain and the individual patient's response and current or previous opioid use. Adults Over 18 Years:The following starting doses are recommended for patients not previously treated with opioids. The initial dose should be adjusted according to previous or concurrent opioid use, overall patient condition, and severity of pain. If analgesic response is inadequate, or if pain severity increases, the dose may be increased.
Switching from Oral Oxycodone to Parenteral Oxycodone:The dose should be based on the following ratio: 2 mg oral oxycodone is equivalent to 1 mg parenteral oxycodone. It should be noted that this is a recommended starting dose. Individual differences require careful dose titration for each patient. Elderly:Oxycodone should be used with caution in elderly patients. The lowest dose should be used with careful titration to achieve pain control. Patients with Renal or Hepatic Impairment:The starting dose should be used with caution in these patients. The recommended starting dose for adults should be reduced by 50% (e.g., total daily dose of 10 mg orally in patients not previously exposed to opioids), and each patient should have their dose carefully titrated to achieve adequate pain control, according to their clinical condition. Pediatric Population:There are no data on the use of oxycodone injection in patients under 18 years of age. Chronic Non-Malignant Pain:Opioids are not the first-line treatment for chronic non-malignant pain. They are not recommended as the only treatment for chronic pain. Chronic pain that can be relieved by strong opioids includes chronic inflammatory pain and degenerative disc disease. Route of Administration:Subcutaneous injection or infusion. Intravenous injection or infusion. Treatment Goals and Discontinuation:Before starting treatment with Oxycodone, a treatment strategy should be agreed upon with the patient, including the treatment goals, duration of treatment, and plan for discontinuation, in accordance with pain treatment guidelines. During treatment, the doctor should have regular contact with the patient to assess the need for continued treatment, consider discontinuation, and adjust the dose as needed. When the patient no longer requires opioid treatment, it is recommended to gradually reduce the dose to prevent withdrawal symptoms. If adequate pain relief is not achieved, consideration should be given to the possibility of hyperalgesia, tolerance, and progression of the underlying disease (see section 4.4 of the Summary of Product Characteristics). Duration of TreatmentOxycodone should not be used for longer than necessary.
Each ampoule is for single use in one patient only. The medicine should be used immediately after opening the ampoule, and any unused solution should be discarded. Chemical and physical in-use stability has been demonstrated for 24 hours at room temperature (15-25°C). From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution/dilution has been carried out in controlled and validated aseptic conditions. Oxycodone 50 mg/ml, undiluted or diluted to 3 mg/ml with sodium chloride 0.9% solution, dextrose 5% solution, or water for injections, is physically and chemically stable for 24 hours at room temperature when stored in polypropylene or polyethylene syringes, polyethylene or PVC tubing, or PVC or EVA infusion bags. Oxycodone 50 mg/ml, undiluted or diluted to 3 mg/ml in infusion fluids used in the studies, and stored in various administration sets, does not need to be protected from light. Improper handling of the undiluted solution after opening the original ampoule, or of the diluted solutions, may compromise the sterility of the product. Further information can be found in the Summary of Product Characteristics.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.